Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.53
+0.40 (2.83%)
At close: Apr 14, 2026, 4:00 PM EDT
14.50
-0.03 (-0.21%)
After-hours: Apr 14, 2026, 5:01 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.24 billion as of April 14, 2026. Its market cap has increased by 83.19% in one year.
Market Cap
2.24B
Enterprise Value
2.21B
1-Year Change
83.19%
Ranking
Category
Stock Price
$14.53
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.24B, a decrease of -53.14%. That is a compound annual growth rate of -10.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 2.18B | -12.24% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 2.15B |
| Aurinia Pharmaceuticals | 2.10B |
| Stoke Therapeutics | 2.03B |
| AnaptysBio | 2.02B |
| Mesoblast | 1.94B |
| Zymeworks | 1.94B |
| Agios Pharmaceuticals | 1.93B |
| Ocular Therapeutix | 1.91B |